Phase II study of regimen of gemcitabine and cisplatin in advanced non-small cell lung cancer

Japanese Journal of Clinical Oncology

Volumn 30, Issue 11, 2000, Pages 494-498

  Chen, Steven C H ^a   Lin, Meng Chin ^a   Chang, John W C ^a   Wang, Su Wei ^a   Lee, Cheng Hei ^a   Tsao, Thomas C Y ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chemotherapy; Cisplatin; Gemcitabine; Non small cell lung cancer; Response

Indexed keywords

CISPLATIN; DOCETAXEL; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADULT; AGED; ANEMIA; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN TISSUE; LUNG CANCER; MALE; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; THROMBOCYTOPENIA; TOXICITY TESTING; VOMITING;

EID: 0034522361     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyd123     Document Type: Article

References (20)

1. Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer: Does chemotherapy make a difference?
2. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
3. Action of 2,2-difluorodeoxycytidine on DNA synthesis
4. Efficacy and safety profile of gemcitabine in non-small cell lung cancer: A phase II study
5. Single agent activity of weekly gemcitabine in advanced non-small cell lung cancer: A phase II study
6. Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
7. Phase I/II study of gemcitabine, an active agent for advanced non-small cell lung cancer (NSCLC)
8. Interaction between cisplatin and gemcitabine in vitro and in vivo
9. 185neu1
10. Optimal two-stage designs for phase II clinical trials
11. Cisplatin
12. Cisplatin and DNA repair in cancer chemotherapy
13. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
14. Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II study
15. Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: Preliminary results
16. Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced non-small-cell lung cancer
17. Phase II trial of gemcitabine plus cisplatin in non-small cell lung cancer: A Hoosier Oncology Group study
18. Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study
19. Combined cisplatin and gemcitabine for non-small cell lung cancer: Influence of scheduling on toxicity and drug delivery